Search - tctmd.com

Displaying 301 - 320 of 977

Sort: Relevancy | Date

News Daily News

Registries Point to Lower Risk of Death With CABG vs PCI in Multivessel CAD

Michael O'Riordan

May 02, 2019

News Daily News

African-American, but Not Hispanic/Latina, Women Have More MIs After Stenting Than White Women

Caitlin E. Cox

April 18, 2019

News Opinion Fellow Talk

Public Reporting and the Budding Interventional Cardiologist

Yashasvi Chugh, MD

March 28, 2019

Presentation CHIP at ACC 2019

Update on PCI for Left Main and Multivessel Disease

Presenter: Gregg W. Stone

March 15, 2019

News Conference News CRT 2019

CABG vs PCI in Left Main Disease: The Debate Continues

Yael L. Maxwell

March 12, 2019

News Conference News CRT 2019

ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice

Yael L. Maxwell

March 07, 2019

News Daily News

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Michael O'Riordan

March 01, 2019

News Daily News

EuroCTO CASTLE: Prediction Model for CTO PCI Success Shows Good Discriminating Ability

L.A. McKeown

February 04, 2019

News Daily News

Similar MACCE in Coronary Patients With Diabetes and CKD Treated With CABG or PCI

L.A. McKeown

January 31, 2019

News Opinion Fellow Talk

Early CHIP-Trained Fellow in the United States Offers Insights: Sanjog Kalra, MD

Luai Tabaza, MD

January 10, 2019

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Daily News

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

L.A. McKeown

November 27, 2018

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Conference News AHA 2018

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Caitlin E. Cox

November 13, 2018

News Conference News AHA 2018

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

Todd Neale

November 12, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

Advertisement

Registries Point to Lower Risk of Death With CABG vs PCI in Multivessel CAD

African-American, but Not Hispanic/Latina, Women Have More MIs After Stenting Than White Women

Public Reporting and the Budding Interventional Cardiologist

Update on PCI for Left Main and Multivessel Disease

CABG vs PCI in Left Main Disease: The Debate Continues

ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

EuroCTO CASTLE: Prediction Model for CTO PCI Success Shows Good Discriminating Ability

Similar MACCE in Coronary Patients With Diabetes and CKD Treated With CABG or PCI

Early CHIP-Trained Fellow in the United States Offers Insights: Sanjog Kalra, MD

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Top News in Coronary Artery Disease: 2018

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

FARGO: FFR No Help for CABG in Patients With Multivessel Disease

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content